☰

Edik M. Blais - Publications

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Computational Systems Biology, Biomedical Engineering, Cancer Metabolism
Website:
www.bme.virginia.edu/csbl/
Tree Info Similar researchers PubMed Report error

25 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Jiang H, Torphy RJ, Steiger K, Hongo H, Ritchie AJ, Kriegsmann M, Horst D, Umetsu SE, Joseph NM, McGregor K, Pishvaian MJ, Blais EM, Lu B, Li M, Hollingsworth M, et al. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix. The Journal of Clinical Investigation. PMID 32749238 DOI: 10.1172/Jci136760  0.313
2020 Lowder CY, Dhir T, Goetz AB, Thomsett HL, Bender J, Tatarian T, Madhavan S, Petricoin EF, Blais E, Lavu H, Winter JM, Posey J, Brody JR, Pishvaian MJ, Yeo CJ. A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience. Surgical Oncology. 33: 118-125. PMID 32561076 DOI: 10.1016/J.Suronc.2020.02.003  0.302
2020 Pishvaian MJ, Blais EM, Brody JR, Lyons E, DeArbeloa P, Hendifar A, Mikhail S, Chung V, Sahai V, Sohal DPS, Bellakbira S, Thach D, Rahib L, Madhavan S, Matrisian LM, et al. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. The Lancet. Oncology. PMID 32135080 DOI: 10.1016/S1470-2045(20)30074-7  0.36
2020 McGrath JS, Honrado C, Moore JH, Adair SJ, Varhue WB, Salahi A, Farmehini V, Goudreau BJ, Nagdas S, Blais EM, Bauer TW, Swami NS. Electrophysiology-based stratification of pancreatic tumorigenicity by label-free single-cell impedance cytometry. Analytica Chimica Acta. 1101: 90-98. PMID 32029124 DOI: 10.1016/J.Aca.2019.12.033  0.353
2020 Hendifar AE, Blais EM, Ng C, Thach D, Gong J, Sohal D, Chung V, Sahai V, Fountzilas C, Mikhail S, Gregory G, Brody JR, Lyons E, DeArbeloa P, Matrisian LM, et al. Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies. Journal of Clinical Oncology. 38: 4641-4641. DOI: 10.1200/Jco.2020.38.15_Suppl.4641  0.364
2019 Gong J, Blais EM, Bender JR, Guan M, Placencio-Hickok V, Petricoin EF, Pishvaian MJ, Gregory G, Tuli R, Hendifar AE. Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations. Oncotarget. 10: 6260-6268. PMID 31692857 DOI: 10.18632/Oncotarget.27265  0.374
2019 Rawls KD, Blais EM, Dougherty BV, Vinnakota KC, Pannala VR, Wallqvist A, Kolling GL, Papin JA. Genome-Scale Characterization of Toxicity-Induced Metabolic Alterations in Primary Hepatocytes. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 31501904 DOI: 10.1093/Toxsci/Kfz197  0.591
2019 Guan M, Gong J, Hendifar AE, Tuli R, Placencio-Hickok V, Bender J, Blais EM, Petricoin E. Multiplatform profiling of pancreatic neuroendocrine tumors (PanNETs) identifies novel co-occurring pathogenic alterations and associations with clinicopathologic factors. Journal of Clinical Oncology. 37: 211-211. DOI: 10.1200/Jco.2019.37.4_Suppl.211  0.369
2019 Petricoin E, Barg D, de Arbeloa PM, Pishvaian MJ, Blais EM. Visualizing real-world outcomes through the lens of a molecular tumor board: Persona-typing pancreatic cancers for clinical decision support. Journal of Clinical Oncology. 37: e18100-e18100. DOI: 10.1200/Jco.2019.37.15_Suppl.E18100  0.37
2019 Pishvaian MJ, Blais EM, DeArbeloa P, Brody JR, Rahib L, Hendifar AE, Mikhail S, Chung V, Sohal D, Picozzi VJ, Mason K, Tibbetts L, Lyons E, Matrisian LM, Madhavan S, et al. Improved overall survival (OS) for advanced pancreatic cancer (PDAC) patients (pts) enrolled in the Know Your Tumor (KYT) program whose tumors harbored highly actionable molecular alterations and who received molecularly-matched therapies (tx). Journal of Clinical Oncology. 37: 4138-4138. DOI: 10.1200/Jco.2019.37.15_Suppl.4138  0.336
2019 Kim H, Ng C, Diniz MA, Montoril MH, Guan M, Brodsky V, Vail E, Tuli R, Blais E, Kim S, Petricoin E, Gong J, Placencio-Hickok VR, Hendifar AE. Abstract C27: Association of mutant KRAS isoforms with weight loss in pancreatic cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-C27  0.327
2019 Matrisian LM, Blais EM, Lyons E, Moravek C, Dearbeloa P, Madhavan S, Brody JR, Petricoin E, Pishvaian MJ. Precision Oncology for Pancreatic Cancer across the United States: the Know Your Tumor ® experience Annals of Oncology. 30: vi30. DOI: 10.1093/Annonc/Mdz348.001  0.365
2018 Rawls KD, Dougherty BV, Blais EM, Stancliffe E, Kolling GL, Vinnakota K, Pannala VR, Wallqvist A, Papin JA. A simplified metabolic network reconstruction to promote understanding and development of flux balance analysis tools. Computers in Biology and Medicine. 105: 64-71. PMID 30584952 DOI: 10.1016/J.Compbiomed.2018.12.010  0.591
2018 Pishvaian MJ, Bender RJ, Halverson D, Rahib L, Hendifar AE, Mikhail S, Chung V, Picozzi VJ, Sohal D, Blais EM, Mason K, Lyons EE, Matrisian LM, Brody JR, Madhavan S, et al. Molecular Profiling of Pancreatic Cancer Patients: Initial Results from the Know Your Tumor Initiative. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29954777 DOI: 10.1158/1078-0432.Ccr-18-0531  0.356
2018 Madhavan S, Blais EM, Bender RJ, Chung VM, Hendifar AE, Mikhail S, Lowery MA, Sohal D, Pohlmann PR, Moore KN, He K, Monk BJ, Coleman RL, Herzog TJ, Petricoin E, et al. A cloud-based virtual tumor board to facilitate treatment recommendations for patients with advanced cancers. Journal of Clinical Oncology. 36: 6508-6508. DOI: 10.1200/Jco.2018.36.15_Suppl.6508  0.316
2018 King JC, Ciupek A, Perloff T, Blanchard A, Mason K, Blais E, Halverson D, Bender J, Madhavan S, Petricoin E. Abstract B26: Addressing gaps in molecular testing for patients with lung cancer Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Aacriaslc18-B26  0.328
2017 Blais EM, Rawls KD, Dougherty BV, Li ZI, Kolling GL, Ye P, Wallqvist A, Papin JA. Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions. Nature Communications. 8: 14250. PMID 28176778 DOI: 10.1038/Ncomms14250  0.586
2017 King JC, Ciupek A, Perloff T, Blanchard A, Mason K, Blais E, Bender RJ, Halverson D, Madhavan S, Petricoin E. LungMATCH: Rates of molecular testing in the lung cancer community. Journal of Clinical Oncology. 35: e20671-e20671. DOI: 10.1200/Jco.2017.35.15_Suppl.E20671  0.316
2017 Bender RJ, Blais E, Kulkarni A, Pishvaian MJ, Halverson D, Brody JR, Petricoin E, Madhavan S. Abstract 5553: A computational model for integrating genomic data with public datasets for molecular tumor board recommendations Cancer Research. 77: 5553-5553. DOI: 10.1158/1538-7445.Am2017-5553  0.345
2014 Newhook TE, Blais EM, Lindberg JM, Adair SJ, Xin W, Lee JK, Papin JA, Parsons JT, Bauer TW. A thirteen-gene expression signature predicts survival of patients with pancreatic cancer and identifies new genes of interest. Plos One. 9: e105631. PMID 25180633 DOI: 10.1371/Journal.Pone.0105631  0.549
2014 Newhook TE, Lindberg JM, Adair SJ, Blais E, Papin J, Gray L, Parsons JT, Bauer TW. Abstract 808: Combination therapy with a MEK inhibitor plus T-type calcium channel inhibitor is highly effective in patient-derived pancreatic ductal adenocarcinomas Cancer Research. 74: 808-808. DOI: 10.1158/1538-7445.Am2014-808  0.544
2013 Walters DM, Stokes JB, Adair SJ, Stelow EB, Borgman CA, Lowrey BT, Xin W, Blais EM, Lee JK, Papin JA, Parsons JT, Bauer TW. Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimens. Plos One. 8: e77065. PMID 24204737 DOI: 10.1371/Journal.Pone.0077065  0.582
2013 Blais EM, Chavali AK, Papin JA. Linking genome-scale metabolic modeling and genome annotation. Methods in Molecular Biology (Clifton, N.J.). 985: 61-83. PMID 23417799 DOI: 10.1007/978-1-62703-299-5_4  0.636
2012 Tilghman RW, Blais EM, Cowan CR, Sherman NE, Grigera PR, Jeffery ED, Fox JW, Blackman BR, Tschumperlin DJ, Papin JA, Parsons JT. Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and protein synthesis. Plos One. 7: e37231. PMID 22623999 DOI: 10.1371/Journal.Pone.0037231  0.561
2010 Burnett LA, Blais EM, Unadkat JD, Hille B, Tilley SL, Babcock DF. Testicular expression of Adora3i2 in Adora3 knockout mice reveals a role of mouse A3Ri2 and human A3Ri3 adenosine receptors in sperm. The Journal of Biological Chemistry. 285: 33662-70. PMID 20732875 DOI: 10.1074/Jbc.M110.156075  0.611
Show low-probability matches.